{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:04:11Z","timestamp":1771232651404,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijpharm.2016.03.050","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T16:36:28Z","timestamp":1459182988000},"page":"98-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Polymeric microcontainers improve oral bioavailability of furosemide"],"prefix":"10.1016","volume":"504","author":[{"given":"Line Hagner","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Melero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan Sylvest","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Garrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.03.050_bib0005","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.drudis.2014.04.011","article-title":"Is nanotechnology a boon for oral drug delivery?","volume":"19","author":"Agrawal","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0168-3659(02)00074-3","article-title":"Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery","volume":"81","author":"Ahmed","year":"2002","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0015","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/smll.200901254","article-title":"Microfabricated devices for enhanced bioadhesive drug delivery: attachment to and small-molecule release through a cell monolayer under flow","volume":"5","author":"Ainslie","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification \u2212 the correlation of in-vitro drug product dissolution and in-vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0025","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s11095-008-9679-z","article-title":"Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional Wood\u2019s apparatus","volume":"25","author":"Avdeef","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijpharm.2012.03.015","article-title":"Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?","volume":"429","author":"Berginc","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0035","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1002\/smll.201201367","article-title":"Multi-reservoir bioadhesive microdevices for independent rate-controlled delivery of multiple drugs","volume":"8","author":"Chirra","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0040","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/adhm.201300676","article-title":"Planar microdevices for enhanced in vivo retention and oral bioavailability of poorly permeable drugs","volume":"3","author":"Chirra","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0045","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/adhm.201300676","article-title":"Planar microdevices for enhanced In vivo retention and oral bioavailability of poorly permeable drugs","volume":"3","author":"Chirra","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11095-008-9803-0","article-title":"Novel platforms for oral drug delivery","volume":"26","author":"Colombo","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/mabi.201000137","article-title":"Barrier properties of gastrointestinal mucus to nanoparticle transport","volume":"10","author":"Crater","year":"2010","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0060","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jps.2600581007","article-title":"Drug absorption II: effect of fasting on intestinal drug absorption","author":"Doluisio","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(01)00738-4","article-title":"Retention and transit of intestinal mucoadhesive films in rat small intestine","volume":"224","author":"Eaimtrakarn","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0075","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2014.11.047","article-title":"Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids","volume":"482","author":"Garc\u00eda-D\u00edaz","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jps.22805","article-title":"Novel furosemide cocrystals and selection of high solubility drug forms","volume":"101","author":"Goud","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0090","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jps.22030","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: furosemide","volume":"99","author":"Granero","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0016-5085(89)90897-4","article-title":"Characterization of the human-colon carcinoma cell-line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6","article-title":"Caco-2 versus Caco-2\/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport","volume":"89","author":"Hilgendorf","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0105","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1023\/A:1015937605100","article-title":"Caco-2Cell monolayers as a model for drug transport across the intestinal-mucosa","volume":"7","author":"Hilgers","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1081\/DDC-100101274","article-title":"PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system","volume":"26","author":"Iannuccelli","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0120","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1116\/1.2806960","article-title":"Optimized plasma-deposited fluorocarbon coating for dry release and passivation of thin SU-8 cantilevers","volume":"25","author":"Keller","year":"2007","journal-title":"J. Vacuum Sci. Technol. B: Microelectron. Nanometer Struct."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mee.2013.03.029","article-title":"Ferromagnetic shadow mask for spray coating of polymer patterns","volume":"110","author":"Keller","year":"2013","journal-title":"Microelectron. Eng."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","article-title":"In vitro models for the prediction of in vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0135","first-page":"7","article-title":"Caco-2 cell lines in drug discovery- an updated perspective","volume":"1","author":"Kumar","year":"2010","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2008.06.007","article-title":"Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: Characterization of conditions for affinity and transport experiments in Caco-2 cells","volume":"35","author":"Larsen","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5173(91)90287-X","article-title":"An estimate of turnover time of intestinal mucus gel layer in the rat insitu loop","volume":"70","author":"Lehr","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5173(91)90287-X","article-title":"An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop","volume":"70","author":"Lehr","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-3659(99)00228-X","article-title":"Lectin-mediated drug delivery: the second generation of bioadhesives","volume":"65","author":"Lehr","year":"2000","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejps.2013.08.025","article-title":"Regional intestinal drug permeation: biopharmaceutics and drug development","volume":"57","author":"Lennern\u00e4s","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/js970332a","article-title":"Human intestinal permeability","volume":"87","author":"Lennernas","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejps.2007.08.002","article-title":"Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms","volume":"32","author":"Lind","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0175","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2001","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.01.014","article-title":"In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: investigation of the single-pass vs. the Doluisio experimental approaches","volume":"480","author":"Lozoya-Agullo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(90)90185-7","article-title":"Physicochemical characterization of furosemide modifications","volume":"60","author":"Matsuda","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0190","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.msec.2013.07.001","article-title":"In vitro and in vivo evaluation of SU-8 biocompatibility","volume":"33","author":"Nemani","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0195","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejpb.2012.03.017","article-title":"Spatial confinement can lead to increased stability of amorphous indomethacin","volume":"81","author":"Nielsen","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejpb.2013.09.002","article-title":"Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster T-max after oral dosing to rats","volume":"85","author":"Nielsen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2013.08.029","article-title":"Biorelevant characterisation of amorphous furosemide salt exhibits conversion to a furosemide hydrate during dissolution","volume":"457","author":"Nielsen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13346-013-0166-7","article-title":"A slow cooling rate of indomethacin melt spatially confined in microcontainers increases the physical stability of the amorphous drug without influencing its biorelevant dissolution behaviour","volume":"4","author":"Nielsen","year":"2014","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10544-015-9958-5","article-title":"pH-triggered drug release from biodegradable microwells for oral drug delivery","volume":"17","author":"Nielsen","year":"2015","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0220","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/bm500464b","article-title":"Alterations in mucus barrier function and matrix structure induced by guluronate oligomers","volume":"15","author":"Nordg\u00e5rd","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0225","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1012111008617","article-title":"Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model","volume":"14","author":"Pade","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/03639040500465991","article-title":"Use of simulated intestinal fluids with Caco-2 cells in rat ileum","volume":"32","author":"Patel","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0235","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejpb.2011.12.011","article-title":"New oral solid dosage form for furosemide oral administration","volume":"80","author":"Perioli","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0240","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1208\/s12249-009-9207-4","article-title":"Permeation of four oral drugs through human intestinal mucosa","volume":"10","author":"Pretorius","year":"2009","journal-title":"Aaps Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0245","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2007.08.024","article-title":"3D lithographically fabricated nanoliter containers for drug delivery","volume":"59","author":"Randall","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0250","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2013.10.026","article-title":"Buccal delivery of metformin: tR146 cell culture model evaluating the use of bioadhesive chitosan discs for drug permeability enhancement","volume":"458","author":"Sander","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption ? comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","author":"Sj\u00f6gren","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejps.2013.05.019","article-title":"In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-sim","volume":"49","author":"Sjogren","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0265","first-page":"1","article-title":"Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs","volume":"9045","author":"Song","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0270","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1021\/nl0700346","article-title":"Aligned arrays of biodegradable poly(epsilon-caprolactone) nanowires and nanofibers by template synthesis","volume":"7","author":"Tao","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(03)00005-1","article-title":"Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery","volume":"88","author":"Tao","year":"2003","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/polym6010179","article-title":"Polyester dendrimers: smart carriers for drug delivery","volume":"6","author":"Twibanire","year":"2014","journal-title":"Polymers"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0290","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2010.11.007","article-title":"Silk fibroin as a vehicle for drug delivery applications","volume":"150","author":"Wenk","year":"2011","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0295","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3109\/03639045.2013.794828","article-title":"Study on the release of fenofibrate nanosuspension in vitro and its correlation with in situ intestinal and in vivo absorption kinetics in rats","volume":"40","author":"Xu","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.050_bib0300","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1517\/17425247.2011.614228","article-title":"Drug delivery strategies for poorly water-soluble drugs: the industrial perspective","volume":"8","author":"van Hoogevest","year":"2011","journal-title":"Expert Opin. Drug Deliv."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T01:28:08Z","timestamp":1567733288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316302599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":60,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0378517316302599"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.050","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric microcontainers improve oral bioavailability of furosemide","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}